Welcome to LookChem.com Sign In|Join Free
  • or
4-(2,3-DICHLOROPHENYL)-4-OXOBUTYRIC ACID is an off-white solid that serves as an intermediate in the preparation of Sertraline, a pharmaceutical compound.
Used in Pharmaceutical Industry:
4-(2,3-DICHLOROPHENYL)-4-OXOBUTYRIC ACID is used as an intermediate in the synthesis of Sertraline for its role in the production of this medication.

32003-41-1

Post Buying Request

32003-41-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

32003-41-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 32003-41-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,0,0 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 32003-41:
(7*3)+(6*2)+(5*0)+(4*0)+(3*3)+(2*4)+(1*1)=51
51 % 10 = 1
So 32003-41-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H8Cl2O3/c11-7-3-1-2-6(10(7)12)8(13)4-5-9(14)15/h1-3H,4-5H2,(H,14,15)

32003-41-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2,3-dichlorophenyl)-4-oxobutanoic acid

1.2 Other means of identification

Product number -
Other names 4-(2,3-dichlorophenyl)-1-oxo-butyric acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:32003-41-1 SDS

32003-41-1Relevant academic research and scientific papers

Synthesis of rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) mimetic and their in vitro characterization as inhibitors of protein-protein interaction

Mahalingam, Poornachandran,Takrouri, Khuloud,Chen, Ting,Sahoo, Rupam,Papadopoulos, Evangelos,Chen, Limo,Wagner, Gerhard,Aktas, Bertal H.,Halperin, Jose A.,Chorev, Michael

, p. 5094 - 5111 (2014/07/08)

The 4EGI-1 is the prototypic inhibitor of eIF4E/eIF4G interaction, a potent inhibitor of translation initiation in vitro and in vivo and an efficacious anticancer agent in animal models of human cancers. We report on the design, synthesis, and in vitro ch

COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION

-

Page/Page column 92-94, (2012/02/01)

Compositions and methods for inhibiting translation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, (4) disorders associated with viral infections, and/or (5) non-proliferative metabolic disorders such as type II diabetes where inhibition of translation initiation is beneficial using the compounds disclosed herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 32003-41-1